Summary
The disposition of fluvoxamine maleate, a serotonin uptake inhibitor with antidepressant properties, was investigated in healthy volunteers.
Five healthy men each ingested 5 mg of thel4C-labelled drug, and excretion of radioactive substances in the urine was measured over 72 hours.
Ten other healthy volunteers each received orally 100 mg of the non-radioactive drug and their plasma fluvoxamine level was measured over 24 hours.
On average 94 % (range: 87–105 %) of an oral dose was excreted in the urine. The excretion rate was biphasic with half-lives of 2.1 hours (1.7 – 3.2 hours) and 14.5 hours (13 – 16 hours).
The fluvoxamine plasma levels reached their maximum between 2 and 8 hours after administration, the peak levels ranging from 31 to 87 ng/ml after 100 mg dose. The plasma level decreased according to first-order kinetics with a half-life of 14.9 hours (range: 12.7 \2- 19.0 hours).
It is concluded that orally administered fluvoxamine is completely absorbed.
Similar content being viewed by others
References
Claassen, V., Davies, J.E., Hertting, G., Plachetz, P. (1977): Fluvoxamine, a specific 5-hydroxytryptamine uptake inhibitor. Br. J. Pharmacol.60, 505–516.
De Wilde, J.E.M. and Doogan, D.P. (1982): Fluvoxamine and chlorimipramine in endogenous depression. J. Affective Disorders,4, 249–259.
Harst, H.E., Jones, D.R., Jarboe, C.H., de Bree, H. (1981): Determination of clovoxamine concentration in human plasma by electron capture chromatography. Clin. Chemistry27, 1210–1212.
Overmars, H., Scherpenisse, P.M., Post L.C. (1983): Fluvoxamine: Metabolism in man. Eur. J. Drug. Metab. Pharmacok. 8,
Metzler, CM., Elfring, G.L., McEwen, A.J. (1974): A package of computer programs for pharmacokinetic modelling. Biometrics, September 1974, p. 562.
Sedman, A.J., Wagner, J.G. (1976): Cstrip, a Fortran computer program for obtaining initial polyexponential estimates. J. Pharm. Sci.65, 1006–10010.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
De Bree, H., Van Der Schoot, J.B. & Post, L.C. Fluvoxamine maleate; Disposition in man. European Journal of Drug Metabolism and Pharmacokinetics 8, 175–179 (1983). https://doi.org/10.1007/BF03188743
Received:
Issue Date:
DOI: https://doi.org/10.1007/BF03188743